Impact BioMedical Inc.

NYSEAM:IBO Stock Report

Market Cap: US$13.3m

Impact BioMedical Management

Management criteria checks 0/4

Impact BioMedical's CEO is Frank Heuszel, appointed in Apr 2023, has a tenure of 1.67 years. directly owns 0.85% of the company’s shares, worth $112.92K. The average tenure of the management team and the board of directors is 1.7 years and 2.8 years respectively.

Key information

Frank Heuszel

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.7yrs
CEO ownership0.8%
Management average tenure1.7yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Frank Heuszel (68 yo)

1.7yrs

Tenure

Mr. Frank D. Heuszel, JD, Esq. serves as Chairman of the Board at Impact BioMedical Inc. He serves as the Chief Executive Officer at Impact BioMedical Inc. since April 2023 and Director since August 2020 a...

Leadership Team

NamePositionTenureCompensationOwnership
Frank Heuszel
Chairman & CEO1.7yrsno data0.85%
$ 112.9k
Todd Macko
CFO. Secretary & Treasurer3.9yrsno data0.0010%
$ 140.1
Mark Suseck
Chief Operating Officer1.3yrsno datano data

1.7yrs

Average Tenure

63yo

Average Age

Experienced Management: IBO's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Frank Heuszel
Chairman & CEO4.3yrsno data0.85%
$ 112.9k
Elise Brownell
Director3.9yrsno datano data
Christian Zimmerman
Independent Directorno datano datano data
Jason Grady
Directorless than a yearno data0.0016%
$ 210.8
David Keene
Independent Directorno datano datano data
Castel Hibbert
Independent Directorno datano datano data
Melissa Sims
Director1.6yrsno datano data

2.8yrs

Average Tenure

64yo

Average Age

Experienced Board: IBO's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Impact BioMedical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution